HealthcareServices

Computer-Aided Drug Discovery Market 2026–2030: Emerging Trends and Forecast Opportunities

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the computer-aided drug discovery market from 2026–2035 with trusted insights from The Business Research Company

How is the Computer-Aided Drug Discovery Market size predicted to change over the forecast window of 2026–2035?

The computer-aided drug discovery market has experienced significant expansion in recent years. Its valuation is projected to rise from $7.56 billion in 2025 to $8.54 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.9%. The historical progression of this market can be ascribed to several factors, including the increasing complexity inherent in drug development, a rise in R&D spending within pharmaceuticals, the broadening scope of computational biology capabilities, the enhanced accessibility of biological data, and the widespread implementation of in silico modeling techniques.

The computer-aided drug discovery market is projected to experience substantial expansion in the coming years, anticipated to reach $13.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is primarily driven by factors such as escalating investments in AI-powered drug discovery, a heightened need for accelerated drug development processes, the broadening scope of personalized medicine research, increased incorporation of machine learning into pharmacology, and the expanded utilization of cloud computing for extensive simulations. Key trends anticipated within this period encompass the increased deployment of AI-driven virtual screening, a surge in the adoption of molecular docking simulations, the deeper integration of genomic data into drug design, the proliferation of cloud-based drug discovery platforms, and an intensified emphasis on refining predictive modeling accuracy.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp

Which Drivers Are Contributing To The Expansion Of The Computer-Aided Drug Discovery Market?

The increasing incidence of cancer cases is anticipated to drive the expansion of the computer-aided drug discovery market in the future. Cancer refers to a collection of illnesses marked by the unchecked proliferation and separation of atypical cells within the organism. This growth in cancer diagnoses stems from multiple elements, including shifts in lifestyle and urban development, environmental contaminants, consumption of tobacco and alcohol, and variations in healthcare availability and public understanding. Computer-aided drug discovery offers capabilities to formulate medicines that precisely target cancer cells exhibiting specific genetic alterations, thereby facilitating the development of more tailored and potent cancer treatments. For example, reports from July 2024 by the Australian Institute of Health and Welfare, an Australia-based government organization, showed roughly 165,000 new cancer diagnoses in 2023. Furthermore, predictions suggest about 204,000 cases will be identified each year by 2033, leading to an estimated 1.9 million cancer cases in total from 2024 to 2033. Consequently, the escalating occurrence of cancer cases stimulates the computer-aided drug discovery market.

What Segment Categories Are Covered In The Computer-Aided Drug Discovery Market?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

What Long-Term Trends Are Expected To Shape The Future Of The Computer-Aided Drug Discovery Market?

Leading companies operating within the computer-aided drug discovery (CADD) market are developing innovative solutions, such as artificial intelligence in drug discovery, to boost the accuracy, speed, and efficiency in identifying potential drug candidates, optimizing lead compounds, and facilitating personalized medicine development. Artificial intelligence (AI) in drug discovery involves the application of AI technologies, including machine learning and deep learning, leveraging advanced algorithms to make the discovery and development of new drugs faster, more efficient, and more precise. For example, in December 2023, Merck KGaA, a Germany-based science and technology company, unveiled AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. This platform, by combining generative AI, machine learning, and computer-aided drug design, accelerates drug development through virtual screening of compounds from over 60 billion chemical targets and recommending optimal synthesis routes. AIDDISONTM is trained on two decades of pharmaceutical R&D data to pinpoint drug-like candidates exhibiting properties like non-toxicity and stability. Moreover, by incorporating Merck’s SynthiaTM retrosynthesis API, the platform optimizes drug manufacturing for enhanced efficiency and sustainability, aiming to reduce the cost and time associated with drug discovery.

Which Leading Companies Dominate The Computer-Aided Drug Discovery Market Share?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Computer-Aided Drug Discovery Market?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Computer-Aided Drug Discovery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19379&type=smp

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Computer Aided Oral And Maxillofacial Surgery Market Report 2026

https://www.thebusinessresearchcompany.com/report/computer-aided-oral-and-maxillofacial-surgery-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795